Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?

作者: Nancy E. Kemeny , Lawrence Schwartz , Mithat Gönen , Adam Yopp , David Gultekin

DOI: 10.1159/000324704

关键词:

摘要: Objectives: This study investigated the efficacy and safety of adding systemic (IV) bevacizumab (Bev) to hepatic arterial infusion (HAI) with floxuridine (FUDR)/dexamethasone (Dex)

参考文章(32)
Sheung-Tat Fan, Chung-Mau Lo, Chi-Leung Liu, Chi-Ming Lam, Wai-Key Yuen, Chun Yeung, John Wong, None, Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Annals of Surgery. ,vol. 229, pp. 322- 330 ,(1999) , 10.1097/00000658-199903000-00004
Fidel David Huitzil-Melendez, Eileen M. O'Reilly, Austin Duffy, Ghassan K. Abou-Alfa, Indications for neoadjuvant, adjuvant, and palliative chemotherapy in the treatment of biliary tract cancers. Surgical Oncology Clinics of North America. ,vol. 18, pp. 361- 379 ,(2009) , 10.1016/J.SOC.2008.12.006
Funda Meric, Yehuda Z. Patt, Steve A. Curley, Judy Chase, Mark S. Roh, J. Nicolas Vauthey, Lee M. Ellis, Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy Annals of Surgical Oncology. ,vol. 7, pp. 490- 495 ,(2000) , 10.1007/S10434-000-0490-2
H. Iwase, M. Shimada, T. Tsuzuki, K. Ina, M. Sugihara, J. Haruta, M. Shinoda, T. Kumada, H. Goto, A Phase II Multi-Center Study of Triple Therapy with Paclitaxel, S-1 and Cisplatin in Patients with Advanced Gastric Cancer Oncology. ,vol. 80, pp. 76- 83 ,(2011) , 10.1159/000328746
Pierre-Alain Clavien, Nazia Selzner, Michael Morse, Markus Selzner, Eric Paulson, Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy Surgery. ,vol. 131, pp. 433- 442 ,(2002) , 10.1067/MSY.2002.122374
N Kemeny, J Daly, P Oderman, M Shike, H Chun, G Petroni, N Geller, Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. Journal of Clinical Oncology. ,vol. 2, pp. 595- 600 ,(1984) , 10.1200/JCO.1984.2.6.595